EBOS Group Limited
EBOSYOTCHealthcare● Active
$24.13
$-1.87(-7.19%)
Market Cap$1.2B
P/E Ratio—
52W High$46.64
52W Low$24.13
EBOS Group Limited (EBOSY) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
EBOSY · earnings · updated Jun 8, 2026
Latest Earnings
Q1 FY2026Report Date: Feb 17, 2026EPS Actual
$1.38
Revenue
$3.82B
Fiscal Period
Q1 FY2026
FY ends December
Report Date
Feb 17, 2026
After Market Close
EBOSY reports quarterly as a OTC-listed Medical - Distribution company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.09
Rev. $41.31B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.09
Rev. Est.$41.31B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| — Q1 FY2026 | Feb 17, 2026 | — | $1.38 | — | $3.82B | — | — |
| — Q3 FY2025 | Aug 27, 2025 | — | $0.80 | — | $2.41B | — | — |
| — Q1 FY2025 | Feb 19, 2025 | — | $0.75 | — | $3.96B | — | — |
| ◌ Q4 FY2024 | Oct 23, 2024 | — | — | — | — | — | — |
| — Q3 FY2024 | Aug 20, 2024 | — | $0.93 | — | $4.35B | — | — |
| ◌ Q2 FY2024 | May 7, 2024 | — | — | — | — | — | — |
| — Q1 FY2024 | Feb 20, 2024 | — | $0.93 | — | $4.29B | — | — |
| — Q2 FY2023 | Jun 30, 2023 | — | $0.86 | — | $4.12B | — | — |
Q1 FY2026
Feb 17, 2026
EPS Actual
$1.38
EPS Est.
—
EPS Surpr.
—
Revenue
$3.82B
Q3 FY2025
Aug 27, 2025
EPS Actual
$0.80
EPS Est.
—
EPS Surpr.
—
Revenue
$2.41B
Q1 FY2025
Feb 19, 2025
EPS Actual
$0.75
EPS Est.
—
EPS Surpr.
—
Revenue
$3.96B
Q4 FY2024
Oct 23, 2024
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q3 FY2024
Aug 20, 2024
EPS Actual
$0.93
EPS Est.
—
EPS Surpr.
—
Revenue
$4.35B
Q2 FY2024
May 7, 2024
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q1 FY2024
Feb 20, 2024
EPS Actual
$0.93
EPS Est.
—
EPS Surpr.
—
Revenue
$4.29B
Q2 FY2023
Jun 30, 2023
EPS Actual
$0.86
EPS Est.
—
EPS Surpr.
—
Revenue
$4.12B
Analyst Estimates
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q1 FY2026 | Feb 17, 2026 | — | $35.03 | $35.03 | +0.00% |
| — Q3 FY2025 | Aug 27, 2025 | — | $41.94 | $41.94 | +0.00% |
| — Q1 FY2025 | Feb 19, 2025 | — | $41.94 | $41.94 | +0.00% |
| — Q3 FY2024 | Aug 20, 2024 | — | $41.94 | $41.94 | +0.00% |
| — Q1 FY2024 | Feb 20, 2024 | — | $31.50 | $31.50 | +0.00% |
| — Q2 FY2023 | Jun 30, 2023 | — | $31.50 | $31.50 | +0.00% |
| — Q4 FY2022 | Dec 31, 2022 | — | $31.50 | $31.50 | +0.00% |
| — Q2 FY2022 | Jun 30, 2022 | — | $31.50 | $31.50 | +0.00% |
Q1 FY2026+0.00%
Report Date
Feb 17, 2026
EPS Beat/Miss
—
Price Before
$35.03
Price After
$35.03
Q3 FY2025+0.00%
Report Date
Aug 27, 2025
EPS Beat/Miss
—
Price Before
$41.94
Price After
$41.94
Q1 FY2025+0.00%
Report Date
Feb 19, 2025
EPS Beat/Miss
—
Price Before
$41.94
Price After
$41.94
Q3 FY2024+0.00%
Report Date
Aug 20, 2024
EPS Beat/Miss
—
Price Before
$41.94
Price After
$41.94
Q1 FY2024+0.00%
Report Date
Feb 20, 2024
EPS Beat/Miss
—
Price Before
$31.50
Price After
$31.50
Q2 FY2023+0.00%
Report Date
Jun 30, 2023
EPS Beat/Miss
—
Price Before
$31.50
Price After
$31.50
Q4 FY2022+0.00%
Report Date
Dec 31, 2022
EPS Beat/Miss
—
Price Before
$31.50
Price After
$31.50
Q2 FY2022+0.00%
Report Date
Jun 30, 2022
EPS Beat/Miss
—
Price Before
$31.50
Price After
$31.50
Beat Rate0 / 8 quarters
Largest Move+0.00% (Q1 FY2026)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: EBOSY ends December
EBOS Group Limited (EBOSY) most recently reported earnings on February 17, 2026 for Q1 FY2026, posting EPS of $1.38 (in line with the analyst consensus of —). The next EBOSY earnings date is expected around September 1, 2026.
Each quarter, investors track EBOSY earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. EBOSY revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
EBOSY's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
EBOSY earnings · 4 questionsEBOS Group Limited's next earnings report is expected around September 1, 2026. EBOSY typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; EBOSY historically reports after market close (AMC).
EBOSY earnings datewhen is EBOSY earningsEBOSY next earnings datewhen does EBOSY report earningsEBOSY earnings calendar
▸ Source: FMP · EBOS Group Limited SEC filings · US GAAP · EBOS Group Limited SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026